CD13-specific ligand facilitates Xanthatin nanomedicine targeting dendritic cells for therapy of refractory allergic rhinitis
Xue Zheng, Chao Sun, Rilei Yu, Xin Chu, Jiahao Xu, Chengcheng Liu, Miaoqing Zhao, Xuelian Xu, Ming Xia, Cheng Wang
Topics & Concepts
CD80CD86In vivoPharmacologyNasal administrationImmune systemChemistryDrug deliveryMedicineImmunologyIn vitroCD40BiologyT cellCytotoxic T cellBiochemistryBiotechnologyOrganic chemistryAllergic Rhinitis and SensitizationAsthma and respiratory diseasesDermatology and Skin Diseases